Litcius/Paper detail

Enhancing neuroprotective effect of aminosalicylic acid-grafted chitosan electrospun fibers for spinal cord injury

Dahao Wang, Haosen Zhao, Chang Xu, Sen Lin, Yue Guo

2023Materials Today Bio11 citationsDOIOpen Access PDF

Abstract

The hyperinflammation microenvironment after spinal cord injury (SCI) remains a great challenge for neural regeneration. Methylprednisolone has been used to reduce the inflammatory response after SCI, but it is controversial due to side effects associated with off-specific targeting effects. In this study, we synthesized in situ 5-ASA grafted chitosan electrospun fibers (ASA-EF) with excellent injectable and self-healing properties to reprogram nerve cells via displaying biological distribution, gene expression, and functional changes. With the support of ASA-EF, the downregulation of inflammatory cytokines expression and the upregulation of anti-inflammatory and regenerative gene expression were found in vitro studies. Moreover, ASA-EF administration polarized macrophages toward proregenerative phenotypes in the injured lesion, and significantly reduced cavity area. In addition, ASA-EF administration increased myelination and regenerating axons and improved motor function (score of 5 versus 2 for SCI group). These results illustrate that the neuroprotective effect of this artificial nanoplatform will facilitate the clinical treatment of traumatic-related diseases via forming a recycled microenvironment that supports regeneration and functional recovery. These particles may be applied to trauma and potential other inflammatory diseases.

Topics & Concepts

NeuroprotectionSpinal cord injuryDownregulation and upregulationRegeneration (biology)PharmacologyMethylprednisoloneSpinal cordMedicineChemistryAnesthesiaCell biologyBiologyBiochemistryGenePsychiatrySpinal Cord Injury ResearchNerve injury and regenerationNerve Injury and Rehabilitation
Enhancing neuroprotective effect of aminosalicylic acid-grafted chitosan electrospun fibers for spinal cord injury | Litcius